Mandate

Vinge has advised D. Carnegie & Co in connection with a directed issue of approximately 6.5 million Class B shares

April 19, 2016

Vinge has advised D. Carnegie & Co AB (publ) (”D. Carnegie”), listed on Nasdaq Stockholm, in connection with the company’s directed cash share issue of 6,539,900 Class B shares at a subscription price of SEK 72.50 per share, raising proceeds of approximately SEK 474,000,000 before transaction costs. The subscription price was determined through an accelerated book-building process. Subscribers in the share issue were approximately 60 Swedish and international institutional investors.

Vinge’s team consisted of Jesper Schönbeck, Sofie Bjärtun and André Isacson.  

Related

Vinge has advised Orexo in connection with the divestment of the US rights to Zubsolv

Vinge has advised Orexo in relation to Swedish law in connection with the divestment of the US rights to Zubsolv to Dexcel Pharma USA.
January 14, 2026

Vinge advises Revivo Group on acquisition of Haapanen

Revivo Group, a comprehensive provider of qualified surface treatment services, has acquired Haapanen, a well-established Finnish specialist company.
January 14, 2026

Vinge advises Morrow Bank in connection with cross-border merger and list change from Oslo Børs to Nasdaq Stockholm

Vinge has advised Morrow Bank in connection with its reverse cross-border merger, whereby Morrow Bank AB is taking over Morrow Bank ASA. The Norwegian bank was previously listed on the Oslo Stock Exchange which was today transferred to Nasdaq Stockholm. Vinge has previously assisted Morrow Bank in obtaining a Swedish banking licence.
January 12, 2026